Variable | Mean ± STD, (95% CI) | Range Min-Max | # Missing | Status | No. | Mean ± STD |
---|---|---|---|---|---|---|
T2 Mapa | 72.77 ± 15.06 (69.36 -75.74) | 47–105 | 17 | B | 68 | 66.78 ± 10.94 |
M | 20 | 93.15 ± 7.14 | ||||
T2 Scaled Ratioa | 0.28 ± 0.26 (0.23 -0.33) | −0.18-1.02 | 1 | B | 84 | 0.19 ± 0.18 |
M | 20 | 0.66 ± 0.21 | ||||
Tumor Myometrium Contrast Ratio on T2a | 0.2 ± 0.75 (0.06 -0.35) | −0.99-2.19 | 4 | B | 82 | −0.02 ± 0.61 |
M | 19 | 1.12 ± 0.55 | ||||
Tumor Psoas Contrast Ratio on T2a | 1.32 ± 1.42 (1.05 -1.58) | −0.61-5.48 | 0 | B | 84 | 0.85 ± 1.02 |
M | 21 | 3.19 ± 1.23 | ||||
Tumor Myometrium Contrast Enhanced Ratioa | 0.11 ± 0.45 (1.03 -1.23) | −0.75-1.49 | 4 | B | 82 | 0.00 ± 0.39 |
M | 19 | 0.61 ± 0.33 | ||||
Tumor Psoas Contrast Enhanced Ratioa | 1.14 ± 0.55 (0.02 -0.20) | −0.14-2.97 | 0 | B | 84 | 1.00 ± 0.44 |
M | 21 | 1.68 ± 0.58 |